SA
Log In
CC
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Hold
19 analysts·Moderate coverage
59
Score
8 Buy (42%)10 Hold (53%)1 Sell (5%)
Rating Breakdown
Strong Buy
00%
Buy
842%
Hold
1053%
Sell
15%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$17.00
-37.5%
Consensus
$19.00
-30.2%
Bull
$30.00
+10.2%
12-Month Target Range19 analysts
$17.00$19.00$30.00
Current $27.22Consensus
Current Price
$27.22
Above Consensus
$8.22

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+5.61%
EPS+59.60%
FY2028
Rev+5.04%
EPS+19.19%

Earnings Surprises

Recent Analyst Actions

Apr 28, 2026Truist Financial
Chemours price target raised to $30 from $27 at Truist
Target:$30.00
+13.3%from $26.48
Apr 10, 2026RBC Capital
Chemours price target raised to $26 from $21 at RBC Capital
Target:$26.00
+13.7%from $22.86
Apr 9, 2026UBS
Chemours price target raised to $29 from $23 at UBS
Target:$29.00
+32.8%from $21.84
Apr 9, 2026Truist Financial
Chemours price target raised to $27 from $21 at Truist
Target:$27.00
+23.6%from $21.84
Feb 23, 2026Jefferies
Chemours (CC) PT Raised to $17 at Jefferies
Target:$17.00
-6.4%from $18.16
Feb 23, 2026UBS
Chemours price target raised to $23 from $18 at UBS
Target:$23.00
+30.4%from $17.64
Feb 23, 2026BMO Capital
Chemours price target lowered to $19 from $20 at BMO Capital
Target:$19.00
+7.4%from $17.68
Feb 23, 2026Mizuho Securities
Chemours price target raised to $17 from $14 at Mizuho
Target:$17.00
-0.2%from $17.04
Feb 23, 2026Morgan Stanley
Chemours price target raised to $17 from $15 at Morgan Stanley
Target:$17.00
-0.2%from $17.04
Jan 21, 2026Truist Financial
Chemours price target raised to $21 from $18 at Truist
Target:$21.00
+37.6%from $15.26
Jan 19, 2026BMO Capital
Chemours price target raised to $20 from $18 at BMO Capital
Target:$20.00
+28.1%from $15.61
Jan 16, 2026RBC Capital
Chemours price target raised to $18 from $16 at RBC Capital
Target:$18.00
+9.6%from $16.42
Nov 10, 2025Truist Financial
Chemours (CC) PT Lowered to $18 at Truist as 'Demand Challenges Persist'
Target:$18.00
+39.5%from $12.90
Oct 16, 2025Mizuho Securities
Chemours price target lowered to $18 from $19 at Mizuho
Target:$18.00
+24.8%from $14.42
Oct 14, 2025RBC Capital
Chemours price target raised to $19 from $15 at RBC Capital
Target:$19.00
+41.4%from $13.44
Oct 6, 2025UBS
Chemours price target raised to $21 from $17 at UBS
Target:$21.00
+31.7%from $15.94
Sep 23, 2025Mizuho Securities
Chemours price target raised to $19 from $16 at Mizuho
Target:$19.00
+11.6%from $17.02
May 7, 2025UBS
Chemours price target lowered to $17 from $18 at UBS
Target:$17.00
+40.5%from $12.10
Apr 15, 2025Mizuho Securities
Chemours price target lowered to $15 from $19 at Mizuho
Target:$15.00
+33.0%from $11.28
Oct 11, 2024RBC Capital
Chemours price target lowered to $28 from $35 at RBC Capital
Target:$28.00
+41.6%from $19.78
Oct 7, 2024BMO Capital
Chemours price target raised to $32 from $30 at BMO Capital
Target:$32.00
+63.5%from $19.57
Aug 6, 2024BMO Capital
Chemours (CC) PT Lowered to $30 at BMO Capital
Target:$30.00
+59.8%from $18.77
Jun 7, 2024Mizuho Securities
Chemours initiated with a Neutral at Mizuho
Target:$25.00
+4.6%from $23.90
May 29, 2024UBS
Box, Inc. (BOX) PT Lowered to $31 at UBS
Target:$31.00
+16.3%from $26.65
Apr 9, 2024BMO Capital
BMO Capital Upgrades Chemours (CC) to Outperform
Target:$34.00
+25.7%from $27.05

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance